Review

Prescribing Drugs to Pregnant Women in Primary Healthcare

Volume: 34 Number: 1 February 29, 2024
TR EN

Prescribing Drugs to Pregnant Women in Primary Healthcare

Abstract

It is crucial for the health of both the mother and the fetus that drugs are only used during pregnancy when absolutely necessary. While appropriate drugs can be used for appropriate indications during pregnancy, it is preferably recommended not to use medication except for the necessary vitamins. In cases where the drug is to be used, the pregnancy category of the medication to be used should be known for the selection of the appropriate medication. Drugs that we regularly prescribe because they are safe should be high on our list of preferences, and if there is chronic drug use, the use of drugs must be regulated with caution and constantly reviewed for appropriateness.

Keywords

Drug Utilization, Pregnancy, Teratogens, İlaç Kullanımı, Gebelik, Teratojenler

References

  1. Miral M, Kızılkaya Beji N. Gebelikte İlaç Kullanımı ve Danışmanlık. Sağlık Bilimleri ve Meslekleri Dergisi. 2017;4(2):142-148.
  2. Zibellini J, Muscat DM, Kizirian N, Gordon A. Effect of health literacy interventions on pregnancy outcomes: A systematic review. Women and Birth 2021;34(2):180-186.
  3. Engeland A, Bjørge T, Klungsøyr K, et al. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiology and drug safety 2018;27(9):995-1004.
  4. Çelikkalp Ü, Yorulmaz F. Gebe Sağlık Çalışanlarının Mesleki Riskleri Ve Koruyucu Yaklaşımlar. Sağlık Bilimleri ve Meslekleri Dergisi 2018;5(2):244-252.
  5. Akpınar E. Gebelikte İlaç Kullanımına Genel Bir Bakış. Ebelik ve Sağlık Bilimleri Dergisi 2021;4(3):330-339.
  6. Pereira CM, Pacagnella RC, Parpinelli MA, et al.Drug use during pregnancy and its consequences: a nested case control study on severe maternal morbidity. Revista Brasileira de Ginecologia e Obstetrícia 2018;40:518-526.
  7. Feibus KB. FDA’s Proposed Rule for Pregnancy and Lactation Labeling: Improving maternal child health through well-informed medicine use. J Med Toxicol 2008;4:284–8.
  8. Kaplan YC, Can H, Demir Ö, et al. İlaçların gebelikte kullanımlarına dair risk iletişiminde yeni dönem: FDA gebelik risk kategorileri değişiyor. Türk Aile Hekimliği Dergisi 2014;18(4):195-198.
  9. Ayuk PT. Use of novel drug therapies during pregnancy and breast-feeding. Case Rep Womens Health. 2023;38:e00511.
  10. Bookstaver PB, Bland CM, Griffin B, et al. A review of antibiotic use in pregnancy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2015;35(11):1052-1062.
APA
Fidancı, İ. (2024). Prescribing Drugs to Pregnant Women in Primary Healthcare. Genel Tıp Dergisi, 34(1), 144-146. https://doi.org/10.54005/geneltip.1213359
AMA
1.Fidancı İ. Prescribing Drugs to Pregnant Women in Primary Healthcare. Genel Tıp Derg. 2024;34(1):144-146. doi:10.54005/geneltip.1213359
Chicago
Fidancı, İzzet. 2024. “Prescribing Drugs to Pregnant Women in Primary Healthcare”. Genel Tıp Dergisi 34 (1): 144-46. https://doi.org/10.54005/geneltip.1213359.
EndNote
Fidancı İ (February 1, 2024) Prescribing Drugs to Pregnant Women in Primary Healthcare. Genel Tıp Dergisi 34 1 144–146.
IEEE
[1]İ. Fidancı, “Prescribing Drugs to Pregnant Women in Primary Healthcare”, Genel Tıp Derg, vol. 34, no. 1, pp. 144–146, Feb. 2024, doi: 10.54005/geneltip.1213359.
ISNAD
Fidancı, İzzet. “Prescribing Drugs to Pregnant Women in Primary Healthcare”. Genel Tıp Dergisi 34/1 (February 1, 2024): 144-146. https://doi.org/10.54005/geneltip.1213359.
JAMA
1.Fidancı İ. Prescribing Drugs to Pregnant Women in Primary Healthcare. Genel Tıp Derg. 2024;34:144–146.
MLA
Fidancı, İzzet. “Prescribing Drugs to Pregnant Women in Primary Healthcare”. Genel Tıp Dergisi, vol. 34, no. 1, Feb. 2024, pp. 144-6, doi:10.54005/geneltip.1213359.
Vancouver
1.İzzet Fidancı. Prescribing Drugs to Pregnant Women in Primary Healthcare. Genel Tıp Derg. 2024 Feb. 1;34(1):144-6. doi:10.54005/geneltip.1213359